{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:00:59Z","timestamp":1771509659358,"version":"3.50.1"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T00:00:00Z","timestamp":1463011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0154616","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T17:55:35Z","timestamp":1463075735000},"page":"e0154616","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Generation and Improvement of Effector Function of a Novel Broadly Reactive and Protective Monoclonal Antibody against Pneumococcal Surface Protein A of Streptococcus pneumoniae"],"prefix":"10.1371","volume":"11","author":[{"given":"Sascha A.","family":"Kristian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah S.","family":"Bubeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian C.","family":"Groff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuguo","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Destito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Laudenslager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia","family":"Koriazova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,5,12]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0029-1202938","article-title":"Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention","volume":"30","author":"JP Lynch 3rd","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.coi.2011.04.002","article-title":"Next generation pneumococcal vaccines","volume":"23","author":"KL Moffitt","year":"2011","journal-title":"Current opinion in immunology"},{"issue":"18","key":"ref3","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.vaccine.2011.02.088","article-title":"Healthcare utilization and cost of pneumococcal disease in the United States","volume":"29","author":"SS Huang","year":"2011","journal-title":"Vaccine"},{"issue":"16","key":"ref4","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.2165\/00003495-200767160-00005","article-title":"Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options","volume":"67","author":"F Van Bambeke","year":"2007","journal-title":"Drugs"},{"issue":"9807","key":"ref5","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"DM Weinberger","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1469-0691.2010.03183.x","article-title":"Streptococcus pneumoniae: virulence factors and variation","volume":"16","author":"AM Mitchell","year":"2010","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/317602","article-title":"Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA","volume":"182","author":"DE Briles","year":"2000","journal-title":"J Infect Dis"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1128\/IAI.68.10.5889-5900.2000","article-title":"Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae","volume":"68","author":"SK Hollingshead","year":"2000","journal-title":"Infect Immun"},{"issue":"Pt 2","key":"ref9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1099\/jmm.0.46268-0","article-title":"Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries","volume":"55","author":"SK Hollingshead","year":"2006","journal-title":"J Med Microbiol"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/IAI.01199-09","article-title":"The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis","volume":"78","author":"CC Daniels","year":"2010","journal-title":"Infect Immun"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.20071168","article-title":"Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies","volume":"205","author":"C Giefing","year":"2008","journal-title":"J Exp Med"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1128\/JB.01148-06","article-title":"Genome sequence of Avery's virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6","volume":"189","author":"JA Lanie","year":"2007","journal-title":"J Bacteriol"},{"issue":"24","key":"ref13","doi-asserted-by":"crossref","first-page":"11140","DOI":"10.1073\/pnas.92.24.11140","article-title":"An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae","volume":"92","author":"LS Havarstein","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF01742253","article-title":"A mouse\/human chimeric anti-(ganglioside GD3) antibody with enhanced antitumor activities","volume":"36","author":"K Shitara","year":"1993","journal-title":"Cancer immunology, immunotherapy: CII"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1158\/0008-5472.CAN-07-6297","article-title":"Engineered antibodies of IgG1\/IgG3 mixed isotype with enhanced cytotoxic activities","volume":"68","author":"A Natsume","year":"2008","journal-title":"Cancer Res"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/bit.20151","article-title":"Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity","volume":"87","author":"N Yamane-Ohnuki","year":"2004","journal-title":"Biotechnology and bioengineering"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CDLI.4.4.415-422.1997","article-title":"Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells","volume":"4","author":"S Romero-Steiner","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1128\/AAC.01565-08","article-title":"Phase 1\/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates","volume":"53","author":"LE Weisman","year":"2009","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1128\/IAI.00291-08","article-title":"Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway","volume":"76","author":"J Yuste","year":"2008","journal-title":"Infect Immun"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.micpath.2007.09.007","article-title":"Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae","volume":"44","author":"MM Ochs","year":"2008","journal-title":"Microb Pathog"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CVI.13.2.165-169.2006","article-title":"Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines","volume":"13","author":"S Romero-Steiner","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/CVI.00370-10","article-title":"Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera","volume":"18","author":"CE Rose","year":"2011","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0161-5890(84)90103-2","article-title":"Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: a novel C1q binding assay","volume":"21","author":"RJ Leatherbarrow","year":"1984","journal-title":"Mol Immunol"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/CVI.00366-10","article-title":"P4 peptide therapy rescues aged mice from fatal pneumococcal sepsis","volume":"17","author":"G Rajam","year":"2010","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM200202213460820","article-title":"Emergence of macrolide resistance during treatment of pneumococcal pneumonia","volume":"346","author":"DM Musher","year":"2002","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"ref26","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"LA Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/514526","article-title":"Resistance patterns of streptococcus pneumoniae from carriers attending day-care centers in southwestern Greece","volume":"25","author":"GA Syrogiannopoulos","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jac\/dkh519","article-title":"Anti-inflammatory effects of macrolides\u2014an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?","volume":"55","author":"GW Amsden","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.exphem.2008.11.006","article-title":"Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcgammaRIIIb and MHC class II expression on the phagocytotic neutrophils","volume":"37","author":"M Shibata-Koyama","year":"2009","journal-title":"Exp Hematol"},{"issue":"5\u20136","key":"ref30","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2006.01.026","article-title":"Engineering of therapeutic antibodies to minimize immunogenicity and optimize function","volume":"58","author":"LG Presta","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/CVI.00430-09","article-title":"Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection","volume":"17","author":"AT Moreno","year":"2010","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1128\/IAI.66.10.4748-4754.1998","article-title":"Comparison of the PspA sequence from Streptococcus pneumoniae EF5668 to the previously identified PspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protection against pneumococci of different capsular types","volume":"66","author":"LS McDaniel","year":"1998","journal-title":"Infect Immun"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/mpat.1994.1078","article-title":"Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260","volume":"17","author":"LS McDaniel","year":"1994","journal-title":"Microb Pathog"},{"issue":"17","key":"ref34","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0264-410X(99)00530-7","article-title":"Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules","volume":"18","author":"GS Nabors","year":"2000","journal-title":"Vaccine"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.vaccine.2013.10.080","article-title":"A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA)","volume":"32","author":"KR Genschmer","year":"2013","journal-title":"Vaccine"},{"issue":"50","key":"ref36","doi-asserted-by":"crossref","first-page":"7157","DOI":"10.1016\/j.vaccine.2012.10.004","article-title":"Development of cross-reactive antibodies to the proline-rich region of pneumococcal surface protein A in children","volume":"30","author":"M Melin","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.1128\/IAI.67.12.6533-6542.1999","article-title":"The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia","volume":"67","author":"A Brooks-Walter","year":"1999","journal-title":"Infect Immun"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.chom.2011.09.009","article-title":"Minimization of bacterial size allows for complement evasion and is overcome by the agglutinating effect of antibody","volume":"10","author":"AB Dalia","year":"2011","journal-title":"Cell host & microbe"},{"key":"ref39","article-title":"Anti-Pneumococcal surface protein A monoclonal antibodies: Correlation between in vitro complement deposition and passive mouse protection","author":"N Khan","year":"2014","journal-title":"Clin Vaccine Immunol"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0171732","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T00:00:00Z","timestamp":1486339200000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0154616","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T19:23:43Z","timestamp":1600543423000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0154616"}},"subtitle":[],"editor":[{"given":"Nicholas J","family":"Mantis","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,12]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0154616","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0171732","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,12]]}}}